Development of a Symptom Tracker for Use by Patients With Heart Failure

Eldrin F. Lewis(Brigham and Women's Hospital), Katherine Waltman Johnson, N Engels(Merck & Co., Inc., Rahway, NJ, USA (United States)), Chun‐Lan Chang(Novartis (United States)), Theresa Coles(RTI Health Solutions), Carla DeMuro(RTI Health Solutions), Donald E. Stull(IQVIA (United States)), Amy Barrett(Churchill Hospital), Stuart Turner(Novartis (United States)), Sandy Lewis(RTI Health Solutions)
Journal of Cardiac Failure
July 22, 2016
10.1016/j.cardfail.2016.06.263
Cited by 0

Related Papers

Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
|Circulation|2014|1k